4.4 Review

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR

Journal

Publisher

DOVE MEDICAL PRESS LTD
DOI: 10.2147/DMSO.S219013

Keywords

cholesterol homeostasis; CVD; HMGCR; LDLR

Funding

  1. Shandong Provincial Natural Science Foundation [ZR2019BH023]
  2. [81900716]

Ask authors/readers for more resources

Cholesterol homeostasis is critical and necessary for the body's functions. Hypercholesterolemia can lead to significant clinical problems, such as cardiovascular disease (CVD). 3-Hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) and low-density lipoprotein cholesterol receptor (LDLR) are major points of control in cholesterol homeostasis. We summarize the regulatory mechanisms of HMGCR and LDLR, which may provide insight for new drug design and development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available